• 湿润烧伤膏治疗糖尿病足截肢术后创面疗效观察
  • Clinical Efficacy Observation of Moist Exposed Burn Ointment (MEBO) in the Treatment of Wounds of Amputation of Diabetic Foot
  • 钟晓光.湿润烧伤膏治疗糖尿病足截肢术后创面疗效观察[J].中国烧伤创疡杂志,2017,(1):48~50.
    DOI:
    中文关键词:  湿润烧伤膏  糖尿病足  截肢  换药  创面  疗效
    英文关键词:MEBO  Diabetic foot  Amputation  Dressing change  Wounds  Curative effect
    基金项目:
    作者单位
    钟晓光 大连医科大学附属第二医院钻石湾院区创面修复科 
    摘要点击次数: 2450
    全文下载次数: 4617
    中文摘要:
          目的 观察? 探讨湿润烧伤膏治疗糖尿病足截肢术后创面的临床疗效? 方法 将2014年8月— 2016年8月大连医科大学附属第二医院钻石湾院区创面修复科收治的60例糖尿病足足趾坏疽患者随机分为治疗 组 (30例) 与对照组 (30例)? 治疗组患者截除坏疽足趾后创面采用湿润烧伤膏换药治疗, 每日1~2次, 直至 创面愈合; 对照组患者截除坏疽足趾后创面采用凡士林油纱换药治疗, 每日1~2次, 直至创面愈合? 对比观察 两组患者治疗过程中的创面疼痛程度? 感染情况及创面愈合时间? 结果 治疗组患者创面愈合时间为 (27.73± 4.10) d, 明显短于对照组的 (35.02±3.76) d; 治疗过程中治疗组无1例患者发生感染, 对照组有5例患者发 生感染, 且治疗组患者的创面疼痛程度明显轻于对照组, 两组疗效对比, P 均<0.05, 差异具有统计学意义? 结论 湿润烧伤膏治疗糖尿病足截肢术后创面, 能有效缓解创面疼痛, 缩短创面愈合时间, 降低感染发生率, 值得临床推广应用?
    英文摘要:
          【Abstract】Objective: To observe and explore the clinical efficacy of Moist Exposed Burn Ointment (MEBO) in the treatment of residual wounds after the diabetic foot amputation. Methods: Sixty patients with diabetic toe gangrene admitted to the Wound Repair Department of The Second Hospital of Dalian Medical University (Zuanshiwan) between August 2014 and August 2016 were randomly divided into a treatment group (30 patients) and a control group (30 patients). The wounds after the amputation of gangrene toes in the treatment group were treated with the dressing change method of MEBO, 1~2 times daily until the wounds were healed; while the wounds in the control group were treated with the dressing change method of Vaseline gauze, also 1~2 times daily until the wounds were healed. The wound pain severity, infection and the wound healing time in the two groups were observed and compared. Results: The wound healing time in the treatment group was (27.73±4.10)d, significantly shorter than (35.02±3.76)d in the control group; during the treatment course, there was no patient developing infection in the treatment group while 5 patients developed infection in the control group, moreover, the wound pain severity in the treatment group was remarkably milder than that in the control group. The curative effects comparison between the two groups showed statistically significant difference (all P<0.05). Conclusion: MEBO should be promoted in the clinical practice of treating diabetic foot amputation wounds in that it can effectively relieve wound pain, shorten wound healing time and reduce the incidence of infection.